These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38016474)
1. SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Zhang W; Dai J; Hou G; Liu H; Zheng S; Wang X; Lin Q; Zhang Y; Lu M; Gong Y; Xiang Z; Yu Y; Hu Y Mol Cell; 2023 Dec; 83(23):4352-4369.e8. PubMed ID: 38016474 [TBL] [Abstract][Full Text] [Related]
2. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900 [TBL] [Abstract][Full Text] [Related]
4. FSP1 is a glutathione-independent ferroptosis suppressor. Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899 [TBL] [Abstract][Full Text] [Related]
5. Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma. Liu MR; Shi C; Song QY; Kang MJ; Jiang X; Liu H; Pei DS Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37695069 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma. Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648 [TBL] [Abstract][Full Text] [Related]
7. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience. Lee J; Roh JL Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895 [TBL] [Abstract][Full Text] [Related]
8. Curcumin Induces Ferroptosis in A549 CD133 Zhou J; Zhang L; Yan J; Hou A; Sui W; Sun M Discov Med; 2023 Jun; 35(176):251-263. PubMed ID: 37272092 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance. Lin X; Zhang Q; Li Q; Deng J; Shen S; Tang M; Ye X; Ji C; Yang Y; Chen Y; Zeng L; Zhao J; Kouwenhoven MBN; Lucero-Prisno DE; Huang J; Li Y; Zhang B; Hu J Drug Resist Updat; 2024 Mar; 73():101032. PubMed ID: 38198846 [TBL] [Abstract][Full Text] [Related]
10. Metabolic Rewiring toward Oxidative Phosphorylation Disrupts Intrinsic Resistance to Ferroptosis of the Colon Adenocarcinoma Cells. Gotorbe C; Durivault J; Meira W; Cassim S; Ždralević M; Pouysségur J; Vučetić M Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552620 [TBL] [Abstract][Full Text] [Related]
11. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Zhou C; Yu T; Zhu R; Lu J; Ouyang X; Zhang Z; Chen Q; Li J; Cui J; Jiang F; Jin KY; Sarapultsev A; Li F; Zhang G; Luo S; Hu D Int J Biol Sci; 2023; 19(5):1471-1489. PubMed ID: 37056925 [TBL] [Abstract][Full Text] [Related]
12. A new thiol-independent mechanism of epithelial host defense against Pseudomonas aeruginosa: iNOS/NO Dar HH; Anthonymuthu TS; Ponomareva LA; Souryavong AB; Shurin GV; Kapralov AO; Tyurin VA; Lee JS; Mallampalli RK; Wenzel SE; Bayir H; Kagan VE Redox Biol; 2021 Sep; 45():102045. PubMed ID: 34167028 [TBL] [Abstract][Full Text] [Related]
13. Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy. Li K; Lin C; Li M; Xu K; He Y; Mao Y; Lu L; Geng W; Li X; Luo Z; Cai K ACS Nano; 2022 Feb; 16(2):2381-2398. PubMed ID: 35041395 [TBL] [Abstract][Full Text] [Related]
14. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis. Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691 [TBL] [Abstract][Full Text] [Related]
15. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib. Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851 [TBL] [Abstract][Full Text] [Related]
16. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy. Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545 [TBL] [Abstract][Full Text] [Related]
17. Temsirolimus inhibits FSP1 enzyme activity to induce ferroptosis and restrain liver cancer progression. Tian RL; Wang TX; Huang ZX; Yang Z; Guan KL; Xiong Y; Wang P; Ye D J Mol Cell Biol; 2024 Sep; ():. PubMed ID: 39313331 [TBL] [Abstract][Full Text] [Related]
18. Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis. Liu W; Zhou Y; Duan W; Song J; Wei S; Xia S; Wang Y; Du X; Li E; Ren C; Wang W; Zhan Q; Wang Q Clin Transl Med; 2021 Sep; 11(9):e517. PubMed ID: 34586745 [TBL] [Abstract][Full Text] [Related]
19. Phase separation of FSP1 promotes ferroptosis. Nakamura T; Hipp C; Santos Dias Mourão A; Borggräfe J; Aldrovandi M; Henkelmann B; Wanninger J; Mishima E; Lytton E; Emler D; Proneth B; Sattler M; Conrad M Nature; 2023 Jul; 619(7969):371-377. PubMed ID: 37380771 [TBL] [Abstract][Full Text] [Related]
20. System X Li FJ; Long HZ; Zhou ZW; Luo HY; Xu SG; Gao LC Front Pharmacol; 2022; 13():910292. PubMed ID: 36105219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]